Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease

Recent Results Cancer Res. 1988:110:198-206. doi: 10.1007/978-3-642-83293-2_31.

Authors

P Preusser¹, H Wilke, W Achterrath, U Fink, P Neuhaus, J Meyer, H J Meyer, J van de Loo

Affiliation

¹ Chirurgische Klinik und Poliklinik, Westfälische Wilhelms-Universität, Münster, FRG.

PMID: 3406503
DOI: 10.1007/978-3-642-83293-2_31

No abstract available

MeSH terms

Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bone Neoplasms / drug therapy
Bone Neoplasms / secondary
Cisplatin / administration & dosage
Cisplatin / adverse effects
Doxorubicin / administration & dosage
Doxorubicin / adverse effects
Drug Evaluation
Etoposide / administration & dosage
Etoposide / adverse effects
Female
Follow-Up Studies
Humans
Liver Neoplasms / drug therapy
Liver Neoplasms / secondary
Lymphatic Metastasis
Male
Middle Aged
Neoplasm Staging
Stomach Neoplasms / drug therapy*

Substances

Etoposide
Doxorubicin
Cisplatin